2023
Risk of incident cardiovascular diseases at national and subnational levels in Iran from 2000 to 2016 and projection through 2030: Insights from Iran STEPS surveys
Ebrahimi H, Masinaei M, Aminorroaya A, Aryan Z, Mehdipour P, Rostam-Abadi Y, Ahmadi N, Moghaddam S, Pishgar F, Ghanbari A, Rezaei N, Takian A, Farzadfar F. Risk of incident cardiovascular diseases at national and subnational levels in Iran from 2000 to 2016 and projection through 2030: Insights from Iran STEPS surveys. PLOS ONE 2023, 18: e0290006. PMID: 37611004, PMCID: PMC10446220, DOI: 10.1371/journal.pone.0290006.Peer-Reviewed Original ResearchConceptsCardiovascular disease riskRisk of cardiovascular diseaseNon-communicable disease risk factor surveillanceCardiovascular diseaseCVD riskWorld Health OrganizationRisk of incident cardiovascular diseaseRisk factor surveillanceFramingham 10-year CVD riskAdult Iranian populationIncident cardiovascular diseaseRisk factor modificationCardiovascular disease risk stratificationEvidence-based decisionsFramingham modelHealth policyNationally representative datasetFactor modificationRisk estimation modelIranian populationHealth OrganizationFraminghamSurvey's backgroundRiskSubnational levelNovel DNMT3B Mutation in a Patient with Immunodeficiency, Centromeric Instability, and Facial Anomalies (ICF) Syndrome and a Bronchopulmonary Collateral Artery
Esmaeilzadeh H, Rezaei N, Aminorroaya A, Rayzan E, Shahkarami S, Seyedpour S, Zoghi S, Aryan Z, Somekh I, Rohlfs M, Klein C. Novel DNMT3B Mutation in a Patient with Immunodeficiency, Centromeric Instability, and Facial Anomalies (ICF) Syndrome and a Bronchopulmonary Collateral Artery. Endocrine Metabolic & Immune Disorders - Drug Targets 2023, 23: 410-415. PMID: 35996251, DOI: 10.2174/1871530322666220822141722.Peer-Reviewed Original ResearchConceptsRecurrent respiratory infectionsFacial anomaliesDNMT3B mutationsRecurrent infectionsCollateral arteriesFamily historyRespiratory infectionsHistory of recurrent respiratory infectionsAssociated with recurrent infectionsCentromeric instabilityFamily history of consanguinityRare autosomal recessive disorderRecurrent episodes of pneumoniaMonthly intravenous immunoglobulinProphylactic trimethoprim-sulfamethoxazolePrimary immune deficiencyBone marrow studyLow-set earsPatent ductus arteriosusEvaluation of neutropeniaEpisodes of pneumoniaHistory of consanguinityMild facial anomaliesAutosomal recessive disorderSystolic cardiac murmur
2022
Association of Opium Consumption and Coronary Artery Ectasia: A Propensity Score-Matched Study
Shafie M, Aminorroaya A, Vasheghani-Farahani A, Jalali A, Baradaran A. Association of Opium Consumption and Coronary Artery Ectasia: A Propensity Score-Matched Study. Archives Of Iranian Medicine 2022, 25: 542-546. PMID: 37543876, DOI: 10.34172/aim.2022.86.Peer-Reviewed Original ResearchConceptsCoronary artery ectasiaCoronary artery diseaseOpium consumptionArtery ectasiaArtery diseaseFamily history of coronary artery diseaseCoronary artery ectasia groupDevelopment of coronary artery ectasiaHistory of coronary artery diseasePrevalence of opium consumptionAssociated with increased riskAssociated with increased risk of atherosclerosisElective coronary angiographyIndependent risk factorControl groupScore-matched studyHyper-inflammatory stateTehran Heart CenterRisk of atherosclerosisNon-consumersFamily historyNo significant differenceCoronary angiographyControl patientsHeart CenterEpidemiology, burden, and attributable risks of infective endocarditis in Iran and its provinces: From 1990 to 2019
Ajam A, Shobeiri P, Keykhaei M, Moghaddam S, Momtazmanesh S, Masinaei M, Esfahani Z, Rezaei N, Naderian M, Aminorroaya A, Rashidi M, Rezaei N, Larijani B, Malakan Rad E, Farzadfar F. Epidemiology, burden, and attributable risks of infective endocarditis in Iran and its provinces: From 1990 to 2019. International Journal Of Cardiology 2022, 363: 202-209. PMID: 35777487, DOI: 10.1016/j.ijcard.2022.06.060.Peer-Reviewed Original ResearchConceptsAge-standardized mortality ratesAge-standardized incidence rateAge-standardized prevalence rateDisability-adjusted life yearsAge-standardized DALY rateMortality rateInfectious disease associated with significant morbidityDALY ratesRisk of infective endocarditisDisease associated with significant morbidityGlobal burdenIncidence rateLife yearsPrevalence ratesEscalating incidenceAge groupsStudy dataInfective endocarditisEpidemiological indicesBurdenSignificant morbidityGBDEndocarditisMortalityProvincial levelHealth system performance in Iran: a systematic analysis for the Global Burden of Disease Study 2019
Collaborators G, Farzadfar F, Naghavi M, Sepanlou S, Moghaddam S, Dangel W, Weaver N, Aminorroaya A, Azadnajafabad S, Koolaji S, Mohammadi E, Rezaei N, Abbas J, Abbasi B, Abbasifard M, Abbasi-Kangevari M, Abbasi-Kangevari Z, Abbastabar H, Abdoli A, Abdollahi M, Abdollahzade S, Abolhassani H, Abrehdari-Tafreshi Z, Aghababaei S, Ahadinezhad B, Ahmadi A, Ahmadi S, Ahmadieh H, Akbari M, Alimohamadi Y, Alipour V, Alizade H, Alvand S, Amini S, Amiri S, Anoushirvani A, Ansari F, Arabloo J, Arab-Zozani M, Aryan Z, Aryannejad A, Asadi-Aliabadi M, Asadi-Pooya A, Asemi Z, Asgari S, Asgary S, Asghari B, Jafarabadi M, Ashrafi E, Atafar Z, Athari S, Avan A, Azadmehr A, Azami H, Azangou-Khyavy M, Azari S, Jafari A, Azarian G, Badirzadeh A, Bahrami E, Bahrami M, Barati N, Bayati M, Bazmandegan G, Behzadifar M, Bijani A, Bohlouli S, Borzouei S, Daneshpajouhnejad P, Dargahi A, Daryani A, Lahijan J, Didehdar M, Djalalinia S, Doaei S, Dorostkar F, Doshmangir L, Edraki M, Emami A, Eshrati B, Eskandarieh S, Esmaeilzadeh F, Faghani S, Fakhar, Farpour H, Farrokhpour H, Harandi M, Fereidouni M, Foroutan M, Ghafourifard M, Ghamari A, Ghamari S, Ghashghaee A, Ghassemi F, Gholami A, Gholamian A, Gholizadeh A, Goharinezhad S, Goleij P, Hadei M, Hafezi-Nejad N, Hariri S, Hasanpoor E, Hassanian-Moghaddam H, Hassanipour S, Hassankhani H, Heidari M, Heidari-Soureshjani R, Hoseini M, Hosseini M, Hosseini M, Hosseini S, Hosseinzadeh A, Hosseinzadeh M, Hoveidamanesh S, Iranpour P, Irvani S, Jaafari J, Jabbarinejad R, Jafarinia M, Jafari-Vayghan H, Jahani M, Jahanmehr N, Jalili M, Janghorban R, Javanmardi F, Joukar F, Kabir A, Kalankesh L, Kalhor R, Kamiab Z, Kamyari N, Matin B, Karimi A, Karimi S, Karyani A, Keikavoosi-Arani L, Keramati M, Keshavarz P, Keykhaei M, Khaleghi A, Khammarnia M, Khanali J, Khayamzadeh M, Khosravi S, Khosravifar M, Khosravizadeh O, Kianipour N, Kolahi A, Maali A, Mahdavi M, Maleki A, Malekpour M, Mansori K, Mansouri B, Mansournia M, Maracy M, Marjani A, Masoudi S, Masoumi S, Masoumi-Asl H, Mayeli M, Nasab E, Mehri F, Miri M, Mirmoeeni S, Mirzaei H, Mirzaei M, Mirzaei R, Mohamadkhani A, Mohammadi H, Mohammadi S, Mohammadi S, Mohammadian-Hafshejani A, Mohammadifard N, Mohammadpourhodki R, Mohseni M, Mokari A, Momtazmanesh S, Moradi A, Moradi M, Moradi Y, Moradi-Joo M, Moradpour F, Moradzadeh M, Moradzadeh R, Mosapour A, Moslehi S, Mouodi S, Naderi M, Naderifar H, Najafpour Z, Nazari J, Nejadghaderi S, Nemati-Anaraki L, Nikpoor A, Nojomi M, Noori M, Nouraei H, Nowroozi A, Oladnabi M, Kan F, Pirestani M, Pirsaheb M, Pourahmadi M, Pourchamani H, Pourjafar H, Pourshams A, Rabiee M, Rabiee N, Rafiei A, Rafiei S, Rahim F, Rahmani A, Rashedi S, Rashedi V, Rashidi A, Rashidi M, Rashidi M, Ravangard R, Rawassizadeh R, Razeghian-Jahromi I, Razeghinia M, Redford S, Rezaei M, Rezaei N, Rezaei N, Rezaei S, Aliabadi H, Rezaeian M, Rezai M, Rezapour A, Rezazadeh H, Rezazadeh-Khadem S, Rostamian M, Sadeghi E, Sadeghi E, Sadeghi M, Sadeghian R, Sadeghian S, Safarpour H, Safdarian, Safi S, Sahebazzamani M, Sahebkar A, Sahraian M, Salahi S, Salamati P, Kafil H, Sarikhani Y, Sarkhosh M, Sarveazad A, Seyed-Nezhad M, Shafaat O, Shaghaghi Z, Shahabi S, Shahin S, Shaker E, Shakiba S, Shamsi M, Shamsoddin E, Sharafi K, Sharifian S, Shaygan M, Sheikhtaheri A, Shiani A, Shirbandi K, Shirkoohi R, Shobeiri P, Shokri A, Siabani S, Sima A, Sofi-Mahmudi A, Soheili A, Soltani S, Soltani-Zangbar M, Soofi M, Tabaeian S, Tabary M, Tahamtan A, Taheri M, Taherkhani A, Tajdini M, Tavolinejad H, Tehrani-Banihashemi A, Tiyuri A, Tohidast S, Vakilian A, Tahbaz S, Vo B, Jabbari S, Yazdi-Feyzabadi V, Yousefi Z, Yousefinezhadi T, Zahir M, Moghadam T, Zamanian M, Zandian H, Zangeneh A, Zarafshan H, Zare F, Dehnavi A, Zarea K, Zarei A, Zareshahrabadi Z, Ziapour A, Zoghi S, Sarrafzadegan N, Rahimi-Movaghar V, Jamshidi H, Mokdad A, Hay S, Murray C, Khosravi A, Moradi-Lakeh M, Asadi-Lari M, Malekzadeh R, Larijani B. Health system performance in Iran: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet 2022, 399: 1625-1645. PMID: 35397236, PMCID: PMC9023870, DOI: 10.1016/s0140-6736(21)02751-3.Peer-Reviewed Original ResearchConceptsDisability-adjusted life yearsNon-communicable diseasesGlobal Burden of Disease StudyBurden of diseaseDisability-adjusted life year ratesBurden of Disease StudyHealth-care systemRisk factorsGlobal burdenAge-standardised DALY ratesHealth system performanceCause-specific mortalityDisease StudyHealth sector changeHealth sector reformCoordinated multisectoral approachBurden of morbidityYLL ratesEstimates of mortalityDALY ratesHealth programmesVital registrationMultisectoral approachAll-causeHealth status
2021
Prevalence and trends of coronary artery disease risk factors and their effect on age of diagnosis in patients with established coronary artery disease: Tehran Heart Center (2005–2015)
Hosseini K, Mortazavi S, Sadeghian S, Ayati A, Nalini M, Aminorroaya A, Tavolinejad H, Salarifar M, Pourhosseini H, Aein A, Jalali A, Bozorgi A, Mehrani M, Kamangar F. Prevalence and trends of coronary artery disease risk factors and their effect on age of diagnosis in patients with established coronary artery disease: Tehran Heart Center (2005–2015). BMC Cardiovascular Disorders 2021, 21: 477. PMID: 34607557, PMCID: PMC8491372, DOI: 10.1186/s12872-021-02293-y.Peer-Reviewed Original ResearchConceptsCAD risk factorsRisk factorsTehran Heart CenterOpium useDisease risk factorsEffect of opium useCoronary artery disease risk factorsArtery disease risk factorsMiddle-income countriesYears earlier ageHigher risk of CADHeart CenterCAD diagnosisCross-sectional studyPublic health challengeArtery diseaseAssociated with higher riskBody-mass indexRisk of CADConventional CAD risk factorsAge of CAD onsetLipid profile componentsTraditional risk factorsHypertension prevalenceAge of diagnosisDisparities and spatial variations of high salt intake in Iran: a subnational study of districts based on the small area estimation method
Azadnajafabad S, Ebrahimi N, Mohammadi E, Ghasemi E, Moghaddam S, Aminorroaya A, Rezaei N, Ghanbari A, Masinaei M, Fateh S, Haghshenas R, Gorgani F, Kazemi A, Dilmaghani-Marand A, Farzadfar F. Disparities and spatial variations of high salt intake in Iran: a subnational study of districts based on the small area estimation method. Public Health Nutrition 2021, 24: 6281-6291. PMID: 34261565, PMCID: PMC11148577, DOI: 10.1017/s1368980021002986.Peer-Reviewed Original ResearchConceptsPrevalence of high salt intakeHigh salt intakeSalt intakeNationwide cross-sectional surveyEstimated prevalenceRisk factor surveillanceEconomic statusNon-communicable diseasesPopulation-wide policiesCross-sectional surveyPublic health issueHigh salt consumptionIran STEPsSocio-economic scaleSmall area estimation methodsStepwise approachDistricts of IranHealth issuesSalt consumptionConcentration indexProvinces of IranRisk factorsIntake measurementsPrevalenceArea estimation methods
2020
The Syncope Unit of Tehran Heart Center
Sadeghian S, Aminorroaya A, Tajdini M. The Syncope Unit of Tehran Heart Center. European Heart Journal 2020, 42: 148-150. PMID: 33346809, DOI: 10.1093/eurheartj/ehaa532.Peer-Reviewed Original ResearchEffects of Angiotensin Receptor Blockers (ARBs) on In-Hospital Outcomes of Patients With Hypertension and Confirmed or Clinically Suspected COVID-19
Soleimani A, Kazemian S, Saleh S, Aminorroaya A, Shajari Z, Hadadi A, Talebpour M, Sadeghian H, Payandemehr P, Sotoodehnia M, Bahreini M, Najmeddin F, Heidarzadeh A, Zivari E, Ashraf H. Effects of Angiotensin Receptor Blockers (ARBs) on In-Hospital Outcomes of Patients With Hypertension and Confirmed or Clinically Suspected COVID-19. American Journal Of Hypertension 2020, 33: 1102-1111. PMID: 32920644, PMCID: PMC7543264, DOI: 10.1093/ajh/hpaa149.Peer-Reviewed Original ResearchConceptsAngiotensin II receptor blockersAngiotensin-converting enzyme inhibitorsIn-hospital outcomesAcute kidney injuryClinically suspected COVID-19Severe COVID-19Receptor blockersEffects of angiotensin receptor blockersWorld Health Organization interim guidanceBenefits of angiotensin-converting enzyme inhibitorsIn-hospital outcomes of patientsAssociated with poor in-hospital outcomesFollowed-up patientsPoor in-hospital outcomesOutcomes of patientsAngiotensin receptor blockersII receptor blockersRetrospective observational studyIn-hospital complicationsIncomplete medical recordsRisk of mortalityClinical suspicionInvasive ventilationHypertensive patientsKidney injury
2018
National and subnational mortality of urological cancers in Iran, 1990–2015
Pishgar F, Amini E, Gohari K, Aminorroaya A, Sheidaei A, Rostamabadi Y, Ebrahimi H, Yoosefi M, Naderimagham S, Rezaei N, Modirian M, Shabestari A, Kompani F, Farzadfar F. National and subnational mortality of urological cancers in Iran, 1990–2015. Asia-Pacific Journal Of Clinical Oncology 2018, 15: e43-e48. PMID: 30270510, DOI: 10.1111/ajco.13074.Peer-Reviewed Original ResearchConceptsAge-standardized death ratesNational death registration systemCause-specific mortality fractionsDeath registration systemMortality rateUrinary organ cancersBurden of diseaseUrological cancersMortality fractionsCancer mortalityEstimated mortality rateRegistration systemRisk factorsDeath rateYears groupOrgan cancersCancer-related deathsStudy trendsMortalityCancerSpatiotemporal modelIranDeathIndividualsDisparities